Grown from a source vial “501Y.V2.H2DELTA 25 Dec 2020 CAT#002” passaged in Vero E6 cells with DMEM & 2% FCS, at 48 hr (CPE+) flask freeze/thawed and clarified by low speed centrifugation. Stored as 1 mL aliquots.
Grown from a source vial “501Y.V2.H2DELTA 25 Dec 2020 CAT#001” passaged in Vero E6 cells with DMEM & 2% FCS, at 48 hr (CPE+) flask freeze/thawed and clarified by low speed centrifugation. Stored as 1 mL aliquots.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This clone belongs to a unique set of HIV-2 biological clones from West African immigrants in The Netherlands. Clones were obtained from patients with non-progressive, aviremic or progressive, viremic HIV-2 infection.
Unit: Vial with 1 ml infectious culture supernatant.
This rabies virus (145/16) is preserved under viral storage medium at -80C. Test for the presence of mycoplasma were performed. The virus has been partially sequenced
This rabies virus (551/16) is preserved under viral storage medium at -80C. Tests for the presence of mycoplasma were performed. The virus has been partially sequenced.